Michigan Medicine, Michigan OPEN, Ann Arbor, Michigan, USA.
University of Michigan School of Dentistry, Ann Arbor, Michigan, USA.
J Dent Educ. 2022 Oct;86(10):1271-1278. doi: 10.1002/jdd.12947. Epub 2022 May 9.
Dental students learn to prescribe pain management medications in dental school, including opioids. Given the current state of opioid-related morbidity and mortality in the US, dental schools should evaluate the context and implementation of opioid prescribing in their dental school clinics (DSCs).
A nationwide survey of deans of clinical operations at all US dental schools was conducted in 2020 related to pain management in their DSC. The Michigan Medicine Institutional Review Board deemed this study unregulated (HUM00151607).
Of the 68 accredited dental schools in the United States, 26 deans of DSCs responded to the survey, yielding a 40% response rate. The survey results showed differences in the levels of education for dental students on opioid prescribing and patient education requirements. A comprehensive curriculum regarding safe opioid prescribing and patient education training was reported by 12 schools. Four dental programs did not have a single guideline or policy in relation to opioids for their dental students.
The implementation of opioid prescribing guidelines and the surrounding context are different among DSCs, which could result in knowledge gaps and confusion for novice providers. Although many dental programs provide extensive opioid safety training, there is room for improvement and standardization to further advance patient care.
牙科学生在牙科学院学习开具疼痛管理药物,包括阿片类药物。鉴于美国目前与阿片类药物相关的发病率和死亡率,牙科学院应评估其牙科诊所(DSC)中阿片类药物处方的背景和实施情况。
2020 年对美国所有牙科学院的临床运营院长进行了一项关于 DSC 疼痛管理的全国性调查。密歇根大学医学机构审查委员会认为这项研究不受监管(HUM00151607)。
在美国 68 所认可的牙科学院中,有 26 名 DSC 院长对调查做出了回应,回应率为 40%。调查结果显示,牙科学生在阿片类药物处方和患者教育要求方面的教育水平存在差异。12 所学校报告了关于安全开具阿片类药物和患者教育培训的综合课程。有四个牙科项目没有为其牙科学生制定任何关于阿片类药物的单一准则或政策。
DSC 之间阿片类药物处方指南的实施和周围环境存在差异,这可能导致新手提供者出现知识差距和混淆。尽管许多牙科项目提供广泛的阿片类药物安全培训,但仍有改进和标准化的空间,以进一步提高患者护理水平。